Genetic testing in steroid-resistant nephrotic syndrome: when and how?

doi:10.1093/ndt/gfv355

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Genetic testing in steroid-resistant nephrotic syndrome: when and how?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 1 Nov 2016

Lovric Svjetlana, Ashraf Shazia, Tan Weizhen, Hildebrandt Friedhelm

Abstract excerpt

Steroid-resistant nephrotic syndrome (SRNS) represents the second most frequent cause of chronic kidney disease in the first three decades of life. It manifests histologically as focal segmental glomerulosclerosis (FSGS) and carries a 33% risk of relapse in a renal transplant. No efficient treatment exists. Identification of single-gene (monogenic) causes of SRNS has moved the glomerular epithelial cell...

Topics

DNA Mutational Analysis
Genetic Markers
Genetic Testing
Humans
Mutation
Nephrotic Syndrome

Source

Open in PubMed Open full text

Identifiers

PMID: 26507970
DOI: 10.1093/ndt/gfv355
PMCID: PMC6367944

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics